Millie D. Long, MD
University of North Carolina at Chapel Hill
Chapel Hill, NC

Millie D. Long MD, MPH earned her doctor of medicine degree at the University of Virginia, where she was a Bowman Scholar. She completed a residency and chief residency in internal medicine at the University of Alabama at Birmingham. She then completed a gastroenterology fellowship at University of North Carolina at Chapel Hill. While at University of North Carolina, she also completed a fellowship in preventive medicine and a masters of public health in epidemiology at the Gillings School of Public Health. She is board certified in internal medicine, preventive medicine and gastroenterology. She is currently Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of North Carolina, as well as Director of the Fellowship Program. Her clinical practice is based at the University of North Carolina Inflammatory Bowel Diseases Center. Dr. Long’s interests include research on prevention of complications of inflammatory bowel disease and women’s health. She is currently an investigator for the CCFA Partners cohort, a prospective cohort focusing upon patient reported outcomes that includes over 14,000 patients living with inflammatory bowel disease. Dr. Long has contributed numerous peer-reviewed publications, book chapters, and review articles to the medical literature. She currently serves as an invited reviewer for journals such as Inflammatory Bowel Diseases, Gastroenterology, and the American Journal of Gastroenterology. She is Associate Editor for the IBD section of the American Journal of Gastroenterology. Dr. Long is a member of the American College of Gastroenterology, where she serves on the Research Committee. She is a member of the American Gastroenterological Association, where she serves on the maintenance of certification committee. She is also a member of the Crohn’s and Colitis Foundation of America, where she chairs the Professional Education Committee.

The Division serves as the clinical home for the Center for Gastrointestinal Biology and Disease, one of 17 federally-funded centers focusing on research in GI diseases. The Division of Gastroenterology and Hepatology runs 3 fellowship training programs: a clinical training program, a clinical outcomes and epidemiology training program, and a basic science training program. The latter two programs are funded by the National Institutes of Health, making the division one of the few in the U.S. with federally funded training programs in both clinical and basic science. Using unique resources including our nationally-acclaimed School of Public Health, the Center for Gastrointestinal Biology and Disease, and UNC’s NIH-funded Clinical and Translational Sciences Award Center, the Division provides an enriched environment to launch an academic career. Advanced training fellowships are offered in endoscopy, liver diseases, and inflammatory bowel disease.

 • Jain A, Nguyen NH, Proudfoot JA, Martin CF, Sandborn WJ, Kappelman MD, Long MD, Singh S. Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases. Am J Gastroenterol. 2019 Apr;114(4):640-647. PMID: 30848727

 • Ona S, James K, Ananthakrishnan AN, Long MD, Martin C, Chen W, Mitchell CM. Association Between Vulvovaginal Discomfort and Activity of Inflammatory Bowel Diseases.Clin Gastroenterol Hepatol. 2019 May 18.. [Epub ahead of print] PMID: 31108226

 • Fan YC, Steele D, Kochar B, Arsene D, Long MD, Dellon ES. Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel Disease. Inflamm Intest Dis. 2019 Apr;3(4):180-186. PMID: 31111034

 • Herfarth H, Barnes EL, Long MD, Isaacs KL, Leith T, Silverstein M, Gerardin Y, Kassam Z. Combined Endoscopic and Oral Fecal Microbiota Transplantation in Patients with Antibiotic-Dependent Pouchitis: Low Clinical Efficacy due to Low Donor Microbial Engraftment. Inflamm Intest Dis. 2019 May;4(1):1-6. PMID: 31172007

 • Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019 Mar;114(3):384-413. PMID: 30840605

 The IBD Partners study, longitudinal cohort of patients living with IBD: www.ibdpartners.org

    Webcasts

    New and Emerging: Anticytokine Therapies in IBD

    Didactic Lecture

    view details >

    Impact of IBD on Healthcare Systems

    Gary Lichtenstein, MD ; David Rubin, MD ; Bruce Sands, MD ; Brennan Spiegel, MD ; Douglas Wolf, MD

    Didactic Lecture

    view details >

    eMonograph

    GI Alliance Payer Summit

    view details >

    Clinical and Managed Care Perspectives in Inflammatory Bowel Disease: Closing the Gap

    view details >

    Addressing Health Outcomes and Rising Costs in the Management of Inflammatory Bowel Disease

    view details >

    The Guide to Guidelines in IBD: Interpretation and Appropriate Use in Clinical Practice

    view details >

    INFORM UC: An Update on Contemporary Management of UC

    view details >

    Breaking The Barriers: Improving Access to Biologic Therapies in IBD

    view details >

    IBD Management: State of the Art in 2018

    view details >

    Improving IBD Care A Personalized Approach to Management

    view details >

    Expert Perspectives in the Management of Inflammatory Bowel Disease (IBD): A Review of Recent Advances

    view details >

    Advances in IBD

    view details >

    Optimizing the Management of Inflammatory Bowel Disease

    view details >

    Webcasts

    New and Emerging: Anticytokine Therapies in IBD

    Didactic Lecture

    view details >

    Impact of IBD on Healthcare Systems

    Gary Lichtenstein, MD ; David Rubin, MD ; Bruce Sands, MD ; Brennan Spiegel, MD ; Douglas Wolf, MD

    Didactic Lecture

    view details >

    Dinner Meetings

    Content available soon

    Audiocasts

    Content available soon!

    Content available soon!

    © Copyright 2013-2025 GI Health Foundation. All rights reserved.
    This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.